Indomethacin is an effective treatment in adults and children with bone Langerhans cell histiocytosis (LCH)

Br J Haematol. 2020 Dec;191(5):e109-e113. doi: 10.1111/bjh.17067. Epub 2020 Aug 30.

Authors

Daniela De Benedittis¹, Sara Mohamed¹, Lorenzo Rizzo², Michelina Santopietro³, Giovanna Palumbo¹, Luisa Cardarelli¹, Mario Roggini⁴, Fiorina Giona¹

Affiliations

¹ Haematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
² Department of Haematology and Oncology, Niguarda Cancer Center, ASST Niguarda Metropolitan Hospital, Milan, Italy.
³ Haematology and Haematopoietic Stem Cells Transplant Unit, AO San Camillo-Forlanini, Rome, Italy.
⁴ Department of "Maternal-and-Child Health" and Urology, Sapienza University of Rome, Rome, Italy.

PMID: 32862434
DOI: 10.1111/bjh.17067

No abstract available

Keywords: Langerhans cell histiocytosis; adults; bone involvement; children; indomethacin.

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Bone Diseases / drug therapy*
Bone Diseases / metabolism
Bone Diseases / pathology
Child
Child, Preschool
Female
Follow-Up Studies
Histiocytosis, Langerhans-Cell / drug therapy*
Histiocytosis, Langerhans-Cell / metabolism
Histiocytosis, Langerhans-Cell / pathology
Humans
Indomethacin / administration & dosage*
Infant
Male
Middle Aged
Retrospective Studies

Substances

Indomethacin